Follow
Policy
Policy is a statement of intent or set of plans intended to achieve a rational goal by a specific organization.
-
FEB 03, 2016 | 10:30 AM
Animal studies performed on behalf of GlaxoSmithKline (GSK) are expected to uphold the core principles established by Corporate Policy 403, ‘Care, Welfare and Treatment of Animals by GS...Speaker: Mary Ann Vasbinder, DVMPresented at: Laboratory Animal Sciences Virtual Event Series 2016
NOV 11, 2015 | 9:00 AM
FDA has generally not enforced applicable regulatory requirements on a group of IVD tests called Laboratory Developed Tests. This use of “enforcement discretion” has been un...Speaker: Katherine (Katie) SerranoNOV 03, 2015 | 8:00 AM
FREE to register and attend! • Patients presenting with persistent abdominal pain and diarrhea are common in clinical practice. Evaluation of these patients, assumin...SEP 30, 2015 | 1:30 PM
Biomarkers, with their associated “tsunami” of publications, represent what is arguably one of the largest areas of scientific inquiry in the history of biomedicine. Touted as the...JUN 11, 2015 | 2:00 PM
Clinical laboratories and, indeed, health care overall, are facing potential paradigm shifts in how innovative and higher quality care are delivered to patients. From ever more precise and ac...Speaker: Thomas SparkmanJUN 10, 2015 | 7:30 AM
CMS continues to make changes to how all healthcare providers are reimbursed in attempts to control the cost of the services provided to Medicare beneficiaries. This has led to value-based r...Speaker: Elissa PassimentJUN 09, 2015 | 7:30 AM
Review of recent, post ACA, health care legislation for impact on physicians and clinical laboratories. Overview of possible new health care legislation and update on Medicare regulatory act...Speaker: Michael BeebeFEB 04, 2015 | 7:30 AMC.E. CREDITS
The transportation of laboratory animals is a critical step in obtaining the proper strain of animal that best fits the researchers needs. Animal Extremist groups have made this transportati...OCT 30, 2014 | 10:30 AM
The era of omics has ushered in the hope for personalized medicine. Proteomic and genomic strategies that allow unbiased identification of genes and proteins and their post-transcriptional a...Speaker: Kimberly Kelly , PhDOCT 29, 2014 | 9:00 AM
Although robust and clinically meaningful biomarkers are key to achieving the current vision for precision (molecularly based), cancer medicine (patient stratification, early diagnosis, drug...Speaker: Anna Barker, PhDAUG 21, 2014 | 12:45 PM
When whole genome and whole exome sequencing are introduced into health care, and offered directly to consumers in commercial settings, the landscape of genetic testing will drastically chang...AUG 20, 2014 | 11:45 AM
Direct-to-consumer (DTC) genetic testing can be understood as including two related aspects: first, the advertising of genetic tests directly to consumers; and second, the direct access or or...MAY 29, 2014 | 9:00 AM
What is the future of personalized medicine? Featuring Dr. Trevor Hawkins (An Introduction to Companion Diagnostics), Dr. Patrick Joseph (Making It Personal for Patients), and Dr. Richard Fra...Speaker: Patrick Joseph, MD and Richard Frank, MDFEB 06, 2014 | 2:00 PM
Intravascular catheterization access for injection and sampling is one of the most common experimental surgical procedures.Catheters and ports have been designed to reduce the problems of occ...Speaker: Oscar A Bermeo Blanco, DVM, RLATG, SRSPresented at: Laboratory Animal Sciences Virtual Event Series 2014
FEB 06, 2014 | 10:00 AM
It is well documented that social housing is fundamental to good welfare for non-human primates (NHPs). Despite this, many laboratory NHPs around the world continue to be singly housed, thoug...NOV 20, 2013 | 10:00 AM
2013 has proven to be a year of paradigmatic shifts in molecular diagnostics reimbursement policy. In this session, we will review and analyze these key policy and payment developments and di...Speaker: Nicole LittmannOCT 17, 2013 | 11:00 AMC.E. CREDITS
Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...Speaker: George Poste, DVM, DSc, PhDOCT 16, 2013 | 10:00 AMC.E. CREDITS
The current paradigm of detecting established cancer (often too late) and treating routinely with cytotoxic drugs is beginning to change. Advanced technologies such as whole genome sequencin...Speaker: Anna Barker, PhDAUG 22, 2013 | 5:00 PMC.E. CREDITS
Malignancies caused by so-called Type I chemical and biological carcinogens provide important opportunities studying early events in cancer development, providing essential information for de...Speaker: Prof. Patrick Tan, MD, PhDPresented at: Genetics and Genomics Virtual Event Series 2013
AUG 22, 2013 | 3:00 PMC.E. CREDITS
The use of ultrahigh throughput diagnostic tests that determine genetic sequence variation to guide patient care is rapidly expanding, fueled by the enormous growth in sequencing platform dev...AUG 22, 2013 | 2:00 PM
The role of the human genome in normal and patho-biology is crucial. Applied in cancer care and in a variety of unknown disorder settings, it can provide key insights and crucial diagnostic/p...AUG 15, 2013 | 9:00 AM
Recent studies show a large prevalence of Vitamin D deficiency and insufficiency in populations of all ages. Concerns about excess supplementation and toxicity have emerged as a result. Th...
FEB 03, 2016 | 10:30 AM
Animal studies performed on behalf of GlaxoSmithKline (GSK) are expected to uphold the core principles established by Corporate Policy 403, ‘Care, Welfare and Treatment of Animals by GS...
Speaker:
Mary Ann Vasbinder, DVM
Presented at: Laboratory Animal Sciences Virtual Event Series 2016
NOV 11, 2015 | 9:00 AM
FDA has generally not enforced applicable regulatory requirements on a group of IVD tests called Laboratory Developed Tests. This use of “enforcement discretion” has been un...
Speaker:
Katherine (Katie) Serrano
NOV 03, 2015 | 8:00 AM
FREE to register and attend!
• Patients presenting with persistent abdominal pain and diarrhea are common in clinical practice. Evaluation of these patients, assumin...
SEP 30, 2015 | 1:30 PM
Biomarkers, with their associated “tsunami” of publications, represent what is arguably one of the largest areas of scientific inquiry in the history of biomedicine. Touted as the...
JUN 11, 2015 | 2:00 PM
Clinical laboratories and, indeed, health care overall, are facing potential paradigm shifts in how innovative and higher quality care are delivered to patients. From ever more precise and ac...
Speaker:
Thomas Sparkman
JUN 10, 2015 | 7:30 AM
CMS continues to make changes to how all healthcare providers are reimbursed in attempts to control the cost of the services provided to Medicare beneficiaries. This has led to value-based r...
Speaker:
Elissa Passiment
JUN 09, 2015 | 7:30 AM
Review of recent, post ACA, health care legislation for impact on physicians and clinical laboratories. Overview of possible new health care legislation and update on Medicare regulatory act...
Speaker:
Michael Beebe
FEB 04, 2015 | 7:30 AM
C.E. CREDITS
The transportation of laboratory animals is a critical step in obtaining the proper strain of animal that best fits the researchers needs. Animal Extremist groups have made this transportati...
OCT 30, 2014 | 10:30 AM
The era of omics has ushered in the hope for personalized medicine. Proteomic and genomic strategies that allow unbiased identification of genes and proteins and their post-transcriptional a...
Speaker:
Kimberly Kelly , PhD
OCT 29, 2014 | 9:00 AM
Although robust and clinically meaningful biomarkers are key to achieving the current vision for precision (molecularly based), cancer medicine (patient stratification, early diagnosis, drug...
Speaker:
Anna Barker, PhD
AUG 21, 2014 | 12:45 PM
When whole genome and whole exome sequencing are introduced into health care, and offered directly to consumers in commercial settings, the landscape of genetic testing will drastically chang...
AUG 20, 2014 | 11:45 AM
Direct-to-consumer (DTC) genetic testing can be understood as including two related aspects: first, the advertising of genetic tests directly to consumers; and second, the direct access or or...
MAY 29, 2014 | 9:00 AM
What is the future of personalized medicine? Featuring Dr. Trevor Hawkins (An Introduction to Companion Diagnostics), Dr. Patrick Joseph (Making It Personal for Patients), and Dr. Richard Fra...
Speaker:
Patrick Joseph, MD and Richard Frank, MD
FEB 06, 2014 | 2:00 PM
Intravascular catheterization access for injection and sampling is one of the most common experimental surgical procedures.Catheters and ports have been designed to reduce the problems of occ...
Speaker:
Oscar A Bermeo Blanco, DVM, RLATG, SRS
Presented at: Laboratory Animal Sciences Virtual Event Series 2014
FEB 06, 2014 | 10:00 AM
It is well documented that social housing is fundamental to good welfare for non-human primates (NHPs). Despite this, many laboratory NHPs around the world continue to be singly housed, thoug...
NOV 20, 2013 | 10:00 AM
2013 has proven to be a year of paradigmatic shifts in molecular diagnostics reimbursement policy. In this session, we will review and analyze these key policy and payment developments and di...
Speaker:
Nicole Littmann
OCT 17, 2013 | 11:00 AM
C.E. CREDITS
Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...
Speaker:
George Poste, DVM, DSc, PhD
OCT 16, 2013 | 10:00 AM
C.E. CREDITS
The current paradigm of detecting established cancer (often too late) and treating routinely with cytotoxic drugs is beginning to change. Advanced technologies such as whole genome sequencin...
Speaker:
Anna Barker, PhD
AUG 22, 2013 | 5:00 PM
C.E. CREDITS
Malignancies caused by so-called Type I chemical and biological carcinogens provide important opportunities studying early events in cancer development, providing essential information for de...
Speaker:
Prof. Patrick Tan, MD, PhD
Presented at: Genetics and Genomics Virtual Event Series 2013
AUG 22, 2013 | 3:00 PM
C.E. CREDITS
The use of ultrahigh throughput diagnostic tests that determine genetic sequence variation to guide patient care is rapidly expanding, fueled by the enormous growth in sequencing platform dev...
AUG 22, 2013 | 2:00 PM
The role of the human genome in normal and patho-biology is crucial. Applied in cancer care and in a variety of unknown disorder settings, it can provide key insights and crucial diagnostic/p...
AUG 15, 2013 | 9:00 AM
Recent studies show a large prevalence of Vitamin D deficiency and insufficiency in populations of all ages. Concerns about excess supplementation and toxicity have emerged as a result. Th...